Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02227836 · ClinicalTrials.gov registry record · NA
Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02227836: Completed NA study, sponsored by Mayo Clinic.
NCT02227836 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02227836, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study is being done to see if allergy patch testing (APT) can help predict effective dietary therapy in patients with eosinophilic esophagitis.
Interventions
- DEVICE Allergy Patch Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02227836
The ClinicalTrials.gov registry entry for NCT02227836 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Allergy Patch Testing is the first listed.
NCT02227836 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02227836 about?
NCT02227836 is a clinical study titled "Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis". This study is being done to see if allergy patch testing (APT) can help predict effective dietary therapy in patients with eosinophilic esophagitis.
What is the current status of trial NCT02227836?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2014-08. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02227836?
The interventions under investigation include: Allergy Patch Testing (DEVICE).
Who is sponsoring clinical trial NCT02227836?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.